Reverie Labs

Reverie Labs is a pharmaceutical company that utilizes machine learning, physics-based modeling, and large-scale computational infrastructure to design new drugs. Reverie's technology includes state-of-the-art predictive tools, novel methods for focused molecule generation, and a scalable cloud framework that allows for unrestricted exploration of chemical space. Reverie's unique approach has led to the discovery of selective brain kinase inhibitors for oncology targets.